Metraipolis › archive › dc_eb525115fa41

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy — Europe PMC PMID:29843633

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/29843633
DOI: 10.1186/s12885-018-4498-z
License (as archived): solo-consultazione
Archived: 2026-10-07T15:15:51.572Z
SHA-256 of the archived text: ac54246d7c84612e2e36d760af32a30fd915fab7fde2984329d4a2c19bf231df
Stable URL of this page: https://metraipolis.com/documento/dc_eb525115fa41

How to cite

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy — Europe PMC PMID:29843633 — Europe PMC (en), https://europepmc.org/article/MED/29843633 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb525115fa41 (Metraipolis archive dc_eb525115fa41, sha256 ac54246d7c84612e2e36d760af32a30fd915fab7fde2984329d4a2c19bf231df)

BibTeX

@misc{dceb525115fa41,
  title = {Changes in ovarian cancer survival during the 20 years before the era of targeted therapy — Europe PMC PMID:29843633},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/29843633},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb525115fa41; sha256 ac54246d7c84612e2e36d760af32a30fd915fab7fde2984329d4a2c19bf231df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/29843633. Agents can read the archived copy with the MCP tool read_document.